A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice
- PMID: 8458579
- DOI: 10.1101/gad.7.4.671
A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice
Abstract
To directly assess c-myc function in cellular proliferation, differentiation, and embryogenesis, we have used homologous recombination in embryonic stem cells to generate both heterozygous and homozygous c-myc mutant ES cell lines. The mutation is a null allele at the protein level. Mouse chimeras from seven heterozygous cell lines transmitted the mutant allele to their offspring. The analysis of embryos from two clones has shown that the mutation is lethal in homozygotes between 9.5 and 10.5 days of gestation. The embryos are generally smaller and retarded in development compared with their littermates. Pathologic abnormalities include the heart, pericardium, neural tube, and delay or failure in turning of the embryo. Heterozygous females have reduced fertility owing to embryonic resorption before 9.5 days of gestation in 14% of implanted embryos. c-Myc protein is necessary for embryonic survival beyond 10.5 days of gestation; however, it appears to be dispensable for cell division both in ES cell lines and in the embryo before that time.
Similar articles
-
Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop.Genes Dev. 1992 Dec;6(12A):2235-47. doi: 10.1101/gad.6.12a.2235. Genes Dev. 1992. PMID: 1459449
-
Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene.Genes Dev. 1992 Dec;6(12A):2248-57. doi: 10.1101/gad.6.12a.2248. Genes Dev. 1992. PMID: 1459450
-
Developmental analysis of the Hba(th-J) mouse mutation: effects on mouse peri-implantation development and identification of two candidate genes.Dev Biol. 1995 Nov;172(1):253-63. doi: 10.1006/dbio.1995.0020. Dev Biol. 1995. PMID: 7589805
-
The N-myc proto-oncogene: developmental expression and in vivo site-directed mutagenesis.Brain Pathol. 1992 Jan;2(1):71-83. Brain Pathol. 1992. PMID: 1341949 Review.
-
C-MYC: evidence for multiple regulatory functions.Semin Cancer Biol. 1990 Feb;1(1):69-80. Semin Cancer Biol. 1990. PMID: 2133113 Review.
Cited by
-
Nilotinib: Disrupting the MYC-MAX Heterocomplex.Bioinform Biol Insights. 2024 Jul 29;18:11779322241267056. doi: 10.1177/11779322241267056. eCollection 2024. Bioinform Biol Insights. 2024. PMID: 39081669 Free PMC article.
-
Body-Wide Inactivation of the Myc-Like Mlx Transcription Factor Network Accelerates Aging and Increases the Lifetime Cancer Incidence.Adv Sci (Weinh). 2024 Sep;11(34):e2401593. doi: 10.1002/advs.202401593. Epub 2024 Jul 8. Adv Sci (Weinh). 2024. PMID: 38976573 Free PMC article.
-
Regulation of Myc transcription by an enhancer cluster dedicated to pluripotency and early embryonic expression.Nat Commun. 2024 May 10;15(1):3931. doi: 10.1038/s41467-024-48258-5. Nat Commun. 2024. PMID: 38729993 Free PMC article.
-
CRL2KLHDC3 and CRL1Fbxw7 cooperatively mediate c-Myc degradation.Oncogene. 2024 Jun;43(25):1917-1929. doi: 10.1038/s41388-024-03048-7. Epub 2024 May 2. Oncogene. 2024. PMID: 38698266
-
N-MYC regulates cell survival via eIF4G1 in inv(16) acute myeloid leukemia.Sci Adv. 2024 Mar;10(9):eadh8493. doi: 10.1126/sciadv.adh8493. Epub 2024 Feb 28. Sci Adv. 2024. PMID: 38416825 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases